Induction of MNK Kinases-Dependent eIF4E Phosphorylation by Inhibitors Targeting BET Proteins Limits Efficacy of BET Inhibitors

Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-18-0768
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

BET Bromodomain Inhibitors Synergize With ATR Inhibitors in Melanoma in Melanoma

Cell Death and Disease
Molecular NeuroscienceImmunologyCell BiologyCancer ResearchCellularMedicine
2017English

Targeting the IGF1R/PI3K/AKT Pathway Sensitizes Ewing Sarcoma to BET Bromodomain Inhibitors

Molecular Cancer Therapeutics
Cancer ResearchOncology
2019English

Applying 89Zr-Transferrin to Study the Pharmacology of Inhibitors to BET Bromodomain Containing Proteins

English

Pharmacological Targeting of BET Proteins Attenuates Radiation-Induced Lung Fibrosis

Scientific Reports
Multidisciplinary
2018English

BET Bromodomain Inhibitors With One-Step Synthesis Discovered From Virtual Screen

Journal of Medicinal Chemistry
Drug DiscoveryMolecular Medicine
2017English

The Role of MNK Proteins and eIF4E Phosphorylation in Breast Cancer Cell Proliferation and Survival

Cancer Biology and Therapy
Cancer ResearchOncologyMolecular MedicinePharmacology
2010English

Dual Targeting of eIF4E by Blocking MNK and mTOR Pathways in Leukemia

Cytokine
BiochemistryAllergyImmunologyHematologyMolecular Biology
2017English

Inhibitors of Mammalian G1 Cyclin-Dependent Kinases.

Genes and Development
GeneticsDevelopmental Biology
1995English

Suppression of Interferon Β Gene Transcription by Inhibitors of Bromodomain and Extra-Terminal (BET) Family Members

Biochemical Journal
BiochemistryCell BiologyMolecular Biology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy